AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM Drug Patent Profile
✉ Email this page to a colleague
When do Amlodipine Besylate And Atorvastatin Calcium patents expire, and when can generic versions of Amlodipine Besylate And Atorvastatin Calcium launch?
Amlodipine Besylate And Atorvastatin Calcium is a drug marketed by Apotex, Dr Reddys, Mylan, and Zydus Pharms. and is included in four NDAs.
The generic ingredient in AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM is amlodipine besylate; atorvastatin calcium. There are fifty drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the amlodipine besylate; atorvastatin calcium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Amlodipine Besylate And Atorvastatin Calcium
A generic version of AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM was approved as amlodipine besylate; atorvastatin calcium by MYLAN on November 29th, 2013.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM?
- What are the global sales for AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM?
- What is Average Wholesale Price for AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM?
Summary for AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM
| US Patents: | 0 |
| Applicants: | 4 |
| NDAs: | 4 |
| Finished Product Suppliers / Packagers: | 6 |
| Clinical Trials: | 3 |
| What excipients (inactive ingredients) are in AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM? | AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM excipients list |
| DailyMed Link: | AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM at DailyMed |
Recent Clinical Trials for AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Alphacait, LLC | Phase 2 |
| Haining Health-Coming Biotech Co., Ltd. | Phase 2 |
| Dr. Reddy's Laboratories Limited | Phase 1 |
See all AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM clinical trials
